Universal Health Services, Inc.
175.78USD
+3.8900 (+2.26%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $5.19▼ | $5.61 | 0 | 12 |
| Next quarter | $5.66▼ | $6.23 | 1 | 11 |
| Current year | $22.53▼ | $23.39 | 2 | 11 |
| Next year | $24.02▼ | $25.35 | 1 | 12 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $6.01 | $5.98 | -0.03 (-0.4%) |
| 2026-03-31 | $5.46 | $5.62 | +0.16 (+2.9%) |
| 2025-12-31 | $5.91 | $5.88 | -0.03 (-0.5%) |
| 2025-09-30 | $4.95 | $5.69 | +0.74 (+14.9%) |
342 ratings from 38 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Reiterated | Sector Perform | $183 | Aug 20, 2026 |
| RBC Capital | Maintained | Sector Perform | $190 $183 | Aug 3, 2026 |
| Goldman Sachs | Maintained | Neutral | $242 $190 | Jul 30, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $212 $191 | Jul 29, 2026 |
| Guggenheim | Maintained | Buy | $195 $189 | Jul 29, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $194 | Jul 29, 2026 |
| Baird | Maintained | Neutral | $204 $166 | Jul 29, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $194 | Jul 28, 2026 |
| Barclays | Maintained | Equal-Weight | $179 $168 | Jul 28, 2026 |
| Guggenheim | Maintained | Buy | $211 $195 | Jul 20, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $165 $166 | Jul 13, 2026 |
| Barclays | Downgraded from Overweight | Equal-Weight | $179 | Jul 8, 2026 |
| TD Cowen | Maintained | Buy | $230 $197 | Jun 22, 2026 |
| UBS | Maintained | Buy | $320 $310 | Apr 30, 2026 |
| TD Cowen | Maintained | Buy | $245 $230 | Apr 29, 2026 |
| RBC Capital | Changed from Sector Performer | Sector Perform | $216 $190 | Apr 29, 2026 |
| Guggenheim | Maintained | Buy | $238 $211 | Apr 29, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $229 $194 | Apr 29, 2026 |
| Baird | Maintained | Neutral | $241 $204 | Apr 29, 2026 |
| Barclays | Maintained | Overweight | $268 $238 | Apr 28, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $235 $212 | Mar 2, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $250 $229 | Feb 27, 2026 |
| Barclays | Maintained | Overweight | $262 $268 | Feb 26, 2026 |
| Barclays | Maintained | Overweight | $263 $262 | Jan 22, 2026 |
| TD Cowen | Maintained | Buy | $251 $245 | Jan 7, 2026 |
54 filings from 10 insiders · 20 buy / 1 sell over 6m
Officers and directors of UHS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SUSSMAN ELLIOT M.D.Director | Grant | 1.2k | — | — | May 20, 2026 |
| SINGER MARIA RUDERMANDirector | Grant | 1.2k | — | — | May 20, 2026 |
| CHEN-LANGENMAYR NINADirector | Grant | 1.2k | — | — | May 20, 2026 |
| MCDONNELL EILEEN C.Director | Grant | 1.2k | — | — | May 20, 2026 |
| NIMETZ WARREN J.Director | Grant | 1.2k | — | — | May 20, 2026 |
| FILTON STEVEN G.Chief Financial Officer | Grant | 6.8k | — | — | Mar 26, 2026 |
| PETERSON MATTHEW JAYOfficer | Grant | 5.6k | — | — | Mar 26, 2026 |
| SIM EDWARD H.Officer | Grant | 6.4k | — | — | Mar 26, 2026 |
| MILLER MARC DChief Executive Officer | Grant | 29.7k | — | — | Mar 26, 2026 |
| MILLER ALAN BOfficer, Director and Beneficial Owner | Grant | 14.2k | — | — | Mar 26, 2026 |
| SUSSMAN ELLIOT M.D.Director | Exercise | 2.5k | $138.80 | $347k | Mar 13, 2026 |
| SUSSMAN ELLIOT M.D.Director | Sell | 674 | $186.35 | $128k | Mar 13, 2026 |
| MILLER ALAN BOfficer, Director and Beneficial Owner | Grant | 33.1k | — | — | Mar 12, 2026 |
| MILLER MARC DChief Executive Officer | Grant | 63.0k | — | — | Mar 12, 2026 |
| SIM EDWARD H.Officer | Grant | 15.0k | — | — | Mar 12, 2026 |
| PETERSON MATTHEW JAYOfficer | Grant | 13.2k | — | — | Mar 12, 2026 |
| FILTON STEVEN G.Chief Financial Officer | Grant | 16.0k | — | — | Mar 12, 2026 |
| FILTON STEVEN G.Chief Financial Officer | Exercise | 83.2k | $138.80 | $12.16M | Mar 12, 2026 |
| MILLER MARC DChief Executive Officer | Exercise | 100.4k | $138.80 | $14.64M | Mar 12, 2026 |
| SINGER MARIA RUDERMANDirector | Exercise | 2.5k | $138.80 | $347k | Mar 12, 2026 |
No analyst notes on UHS yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 6 | 12 | 0 | 1 | Hold2.70 |
| 1 mo ago | 1 | 6 | 12 | 0 | 1 | Hold2.70 |
| 2 mo ago | 1 | 6 | 12 | 0 | 1 | Hold2.70 |
| 3 mo ago | 2 | 6 | 11 | 0 | 1 | Hold2.60 |